調査レポート | • レポートコード：GIR-2104Z11941 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥494,160 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥741,240 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥988,320 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、網膜バイオシミラーのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。網膜バイオシミラーの種類別市場規模（黄斑変性症薬、糖尿病性眼疾患薬、黄斑パッカー薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・網膜バイオシミラーの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Novartis (Sandoz)、Takeda、Bayer、Genentech、Pfenex、Reliance Life Sciences、Hetero Drugs、Intas Pharmaceuticals、Santo Holding、Regeneron Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：黄斑変性症薬、糖尿病性眼疾患薬、黄斑パッカー薬、その他 ・用途別分析2016年-2026年：病院薬局、小売薬局、オンライン薬局 ・網膜バイオシミラーの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・網膜バイオシミラーのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・網膜バイオシミラーのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・網膜バイオシミラーの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・網膜バイオシミラーの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Retinal Biosimilars market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Retinal Biosimilars size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Retinal Biosimilars market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Retinal Biosimilars market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Macular Degeneration Drugs
Diabetic Eye Disease Drugs
Macular Pucker Drugs
Others
Market segment by Application, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by players, this report covers
Novartis (Sandoz)
Takeda
Bayer
Genentech
Pfenex
Reliance Life Sciences
Hetero Drugs
Intas Pharmaceuticals
Santo Holding
Regeneron Pharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Retinal Biosimilars
1.2 Classification of Retinal Biosimilars by Type
1.2.1 Overview: Global Retinal Biosimilars Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Retinal Biosimilars Revenue Market Share by Type in 2020
1.2.3 Macular Degeneration Drugs
1.2.4 Diabetic Eye Disease Drugs
1.2.5 Macular Pucker Drugs
1.2.6 Others
1.3 Global Retinal Biosimilars Market by Application
1.3.1 Overview: Global Retinal Biosimilars Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Retinal Biosimilars Market Size & Forecast
1.5 Global Retinal Biosimilars Market Size and Forecast by Region
1.5.1 Global Retinal Biosimilars Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Retinal Biosimilars Market Size by Region, (2016-2021)
1.5.3 North America Retinal Biosimilars Market Size and Prospect (2016-2026)
1.5.4 Europe Retinal Biosimilars Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Retinal Biosimilars Market Size and Prospect (2016-2026)
1.5.6 South America Retinal Biosimilars Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Retinal Biosimilars Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Retinal Biosimilars Market Drivers
1.6.2 Retinal Biosimilars Market Restraints
1.6.3 Retinal Biosimilars Trends Analysis
2 Company Profiles
2.1 Novartis (Sandoz)
2.1.1 Novartis (Sandoz) Details
2.1.2 Novartis (Sandoz) Major Business
2.1.3 Novartis (Sandoz) Retinal Biosimilars Product and Solutions
2.1.4 Novartis (Sandoz) Retinal Biosimilars Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Novartis (Sandoz) Recent Developments and Future Plans
2.2 Takeda
2.2.1 Takeda Details
2.2.2 Takeda Major Business
2.2.3 Takeda Retinal Biosimilars Product and Solutions
2.2.4 Takeda Retinal Biosimilars Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Takeda Recent Developments and Future Plans
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Retinal Biosimilars Product and Solutions
2.3.4 Bayer Retinal Biosimilars Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bayer Recent Developments and Future Plans
2.4 Genentech
2.4.1 Genentech Details
2.4.2 Genentech Major Business
2.4.3 Genentech Retinal Biosimilars Product and Solutions
2.4.4 Genentech Retinal Biosimilars Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Genentech Recent Developments and Future Plans
2.5 Pfenex
2.5.1 Pfenex Details
2.5.2 Pfenex Major Business
2.5.3 Pfenex Retinal Biosimilars Product and Solutions
2.5.4 Pfenex Retinal Biosimilars Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Pfenex Recent Developments and Future Plans
2.6 Reliance Life Sciences
2.6.1 Reliance Life Sciences Details
2.6.2 Reliance Life Sciences Major Business
2.6.3 Reliance Life Sciences Retinal Biosimilars Product and Solutions
2.6.4 Reliance Life Sciences Retinal Biosimilars Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Reliance Life Sciences Recent Developments and Future Plans
2.7 Hetero Drugs
2.7.1 Hetero Drugs Details
2.7.2 Hetero Drugs Major Business
2.7.3 Hetero Drugs Retinal Biosimilars Product and Solutions
2.7.4 Hetero Drugs Retinal Biosimilars Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Hetero Drugs Recent Developments and Future Plans
2.8 Intas Pharmaceuticals
2.8.1 Intas Pharmaceuticals Details
2.8.2 Intas Pharmaceuticals Major Business
2.8.3 Intas Pharmaceuticals Retinal Biosimilars Product and Solutions
2.8.4 Intas Pharmaceuticals Retinal Biosimilars Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Intas Pharmaceuticals Recent Developments and Future Plans
2.9 Santo Holding
2.9.1 Santo Holding Details
2.9.2 Santo Holding Major Business
2.9.3 Santo Holding Retinal Biosimilars Product and Solutions
2.9.4 Santo Holding Retinal Biosimilars Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Santo Holding Recent Developments and Future Plans
2.10 Regeneron Pharmaceuticals
2.10.1 Regeneron Pharmaceuticals Details
2.10.2 Regeneron Pharmaceuticals Major Business
2.10.3 Regeneron Pharmaceuticals Retinal Biosimilars Product and Solutions
2.10.4 Regeneron Pharmaceuticals Retinal Biosimilars Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Regeneron Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Retinal Biosimilars Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Retinal Biosimilars Players Market Share
3.2.2 Top 10 Retinal Biosimilars Players Market Share
3.2.3 Market Competition Trend
3.3 Retinal Biosimilars Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Retinal Biosimilars Revenue and Market Share by Type (2016-2021)
4.2 Global Retinal Biosimilars Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Retinal Biosimilars Revenue Market Share by Application (2016-2021)
5.2 Retinal Biosimilars Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Retinal Biosimilars Revenue by Type (2016-2026)
6.2 North America Retinal Biosimilars Revenue by Application (2016-2026)
6.3 North America Retinal Biosimilars Market Size by Country
6.3.1 North America Retinal Biosimilars Revenue by Country (2016-2026)
6.3.2 United States Retinal Biosimilars Market Size and Forecast (2016-2026)
6.3.3 Canada Retinal Biosimilars Market Size and Forecast (2016-2026)
6.3.4 Mexico Retinal Biosimilars Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Retinal Biosimilars Revenue by Type (2016-2026)
7.2 Europe Retinal Biosimilars Revenue by Application (2016-2026)
7.3 Europe Retinal Biosimilars Market Size by Country
7.3.1 Europe Retinal Biosimilars Revenue by Country (2016-2026)
7.3.2 Germany Retinal Biosimilars Market Size and Forecast (2016-2026)
7.3.3 France Retinal Biosimilars Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Retinal Biosimilars Market Size and Forecast (2016-2026)
7.3.5 Russia Retinal Biosimilars Market Size and Forecast (2016-2026)
7.3.6 Italy Retinal Biosimilars Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Retinal Biosimilars Revenue by Type (2016-2026)
8.2 Asia-Pacific Retinal Biosimilars Revenue by Application (2016-2026)
8.3 Asia-Pacific Retinal Biosimilars Market Size by Region
8.3.1 Asia-Pacific Retinal Biosimilars Revenue by Region (2016-2026)
8.3.2 China Retinal Biosimilars Market Size and Forecast (2016-2026)
8.3.3 Japan Retinal Biosimilars Market Size and Forecast (2016-2026)
8.3.4 South Korea Retinal Biosimilars Market Size and Forecast (2016-2026)
8.3.5 India Retinal Biosimilars Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Retinal Biosimilars Market Size and Forecast (2016-2026)
8.3.7 Australia Retinal Biosimilars Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Retinal Biosimilars Revenue by Type (2016-2026)
9.2 South America Retinal Biosimilars Revenue by Application (2016-2026)
9.3 South America Retinal Biosimilars Market Size by Country
9.3.1 South America Retinal Biosimilars Revenue by Country (2016-2026)
9.3.2 Brazil Retinal Biosimilars Market Size and Forecast (2016-2026)
9.3.3 Argentina Retinal Biosimilars Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Retinal Biosimilars Revenue by Type (2016-2026)
10.2 Middle East & Africa Retinal Biosimilars Revenue by Application (2016-2026)
10.3 Middle East & Africa Retinal Biosimilars Market Size by Country
10.3.1 Middle East & Africa Retinal Biosimilars Revenue by Country (2016-2026)
10.3.2 Turkey Retinal Biosimilars Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Retinal Biosimilars Market Size and Forecast (2016-2026)
10.3.4 UAE Retinal Biosimilars Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Retinal Biosimilars Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Retinal Biosimilars Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Retinal Biosimilars Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Retinal Biosimilars Revenue (USD Million) by Region (2016-2021)
Table 5. Global Retinal Biosimilars Revenue Market Share by Region (2021-2026)
Table 6. Novartis (Sandoz) Corporate Information, Head Office, and Major Competitors
Table 7. Novartis (Sandoz) Major Business
Table 8. Novartis (Sandoz) Retinal Biosimilars Product and Solutions
Table 9. Novartis (Sandoz) Retinal Biosimilars Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Takeda Corporate Information, Head Office, and Major Competitors
Table 11. Takeda Major Business
Table 12. Takeda Retinal Biosimilars Product and Solutions
Table 13. Takeda Retinal Biosimilars Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bayer Corporate Information, Head Office, and Major Competitors
Table 15. Bayer Major Business
Table 16. Bayer Retinal Biosimilars Product and Solutions
Table 17. Bayer Retinal Biosimilars Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Genentech Corporate Information, Head Office, and Major Competitors
Table 19. Genentech Major Business
Table 20. Genentech Retinal Biosimilars Product and Solutions
Table 21. Genentech Retinal Biosimilars Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Pfenex Corporate Information, Head Office, and Major Competitors
Table 23. Pfenex Major Business
Table 24. Pfenex Retinal Biosimilars Product and Solutions
Table 25. Pfenex Retinal Biosimilars Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Reliance Life Sciences Corporate Information, Head Office, and Major Competitors
Table 27. Reliance Life Sciences Major Business
Table 28. Reliance Life Sciences Retinal Biosimilars Product and Solutions
Table 29. Reliance Life Sciences Retinal Biosimilars Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Hetero Drugs Corporate Information, Head Office, and Major Competitors
Table 31. Hetero Drugs Major Business
Table 32. Hetero Drugs Retinal Biosimilars Product and Solutions
Table 33. Hetero Drugs Retinal Biosimilars Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Intas Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 35. Intas Pharmaceuticals Major Business
Table 36. Intas Pharmaceuticals Retinal Biosimilars Product and Solutions
Table 37. Intas Pharmaceuticals Retinal Biosimilars Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Santo Holding Corporate Information, Head Office, and Major Competitors
Table 39. Santo Holding Major Business
Table 40. Santo Holding Retinal Biosimilars Product and Solutions
Table 41. Santo Holding Retinal Biosimilars Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Regeneron Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 43. Regeneron Pharmaceuticals Major Business
Table 44. Regeneron Pharmaceuticals Retinal Biosimilars Product and Solutions
Table 45. Regeneron Pharmaceuticals Retinal Biosimilars Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Retinal Biosimilars Revenue (USD Million) by Players (2019-2021)
Table 47. Global Retinal Biosimilars Revenue Share by Players (2019-2021)
Table 48. Breakdown of Retinal Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Retinal Biosimilars Players Head Office, Products and Services Provided
Table 50. Retinal Biosimilars Mergers & Acquisitions in the Past Five Years
Table 51. Retinal Biosimilars New Entrants and Expansion Plans
Table 52. Global Retinal Biosimilars Revenue (USD Million) by Type (2016-2021)
Table 53. Global Retinal Biosimilars Revenue Share by Type (2016-2021)
Table 54. Global Retinal Biosimilars Revenue Forecast by Type (2021-2026)
Table 55. Global Retinal Biosimilars Revenue by Application (2016-2021)
Table 56. Global Retinal Biosimilars Revenue Forecast by Application (2021-2026)
Table 57. North America Retinal Biosimilars Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Retinal Biosimilars Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Retinal Biosimilars Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Retinal Biosimilars Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Retinal Biosimilars Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Retinal Biosimilars Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Retinal Biosimilars Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Retinal Biosimilars Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Retinal Biosimilars Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Retinal Biosimilars Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Retinal Biosimilars Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Retinal Biosimilars Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Retinal Biosimilars Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Retinal Biosimilars Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Retinal Biosimilars Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Retinal Biosimilars Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Retinal Biosimilars Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Retinal Biosimilars Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Retinal Biosimilars Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Retinal Biosimilars Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Retinal Biosimilars Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Retinal Biosimilars Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Retinal Biosimilars Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Retinal Biosimilars Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Retinal Biosimilars Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Retinal Biosimilars Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Retinal Biosimilars Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Retinal Biosimilars Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Retinal Biosimilars Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Retinal Biosimilars Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Retinal Biosimilars Picture
Figure 2. Global Retinal Biosimilars Revenue Market Share by Type in 2020
Figure 3. Macular Degeneration Drugs
Figure 4. Diabetic Eye Disease Drugs
Figure 5. Macular Pucker Drugs
Figure 6. Others
Figure 7. Retinal Biosimilars Revenue Market Share by Application in 2020
Figure 8. Hospital Pharmacies Picture
Figure 9. Retail Pharmacies Picture
Figure 10. Online Pharmacies Picture
Figure 11. Global Retinal Biosimilars Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Retinal Biosimilars Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Retinal Biosimilars Revenue Market Share by Region (2016-2026)
Figure 14. Global Retinal Biosimilars Revenue Market Share by Region in 2020
Figure 15. North America Retinal Biosimilars Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Retinal Biosimilars Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Retinal Biosimilars Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Retinal Biosimilars Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Retinal Biosimilars Market Drivers
Figure 20. Retinal Biosimilars Market Restraints
Figure 21. Retinal Biosimilars Market Trends
Figure 22. Novartis (Sandoz) Recent Developments and Future Plans
Figure 23. Takeda Recent Developments and Future Plans
Figure 24. Bayer Recent Developments and Future Plans
Figure 25. Genentech Recent Developments and Future Plans
Figure 26. Pfenex Recent Developments and Future Plans
Figure 27. Reliance Life Sciences Recent Developments and Future Plans
Figure 28. Hetero Drugs Recent Developments and Future Plans
Figure 29. Intas Pharmaceuticals Recent Developments and Future Plans
Figure 30. Santo Holding Recent Developments and Future Plans
Figure 31. Regeneron Pharmaceuticals Recent Developments and Future Plans
Figure 33. Global Retinal Biosimilars Revenue Share by Players in 2020
Figure 34. Retinal Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Retinal Biosimilars Revenue Market Share in 2020
Figure 36. Global Top 10 Players Retinal Biosimilars Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Retinal Biosimilars Revenue Share by Type in 2020
Figure 39. Global Retinal Biosimilars Market Share Forecast by Type (2021-2026)
Figure 40. Global Retinal Biosimilars Revenue Share by Application in 2020
Figure 41. Global Retinal Biosimilars Market Share Forecast by Application (2021-2026)
Figure 42. North America Retinal Biosimilars Sales Market Share by Type (2016-2026)
Figure 43. North America Retinal Biosimilars Sales Market Share by Application (2016-2026)
Figure 44. North America Retinal Biosimilars Revenue Market Share by Country (2016-2026)
Figure 45. United States Retinal Biosimilars Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Retinal Biosimilars Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Retinal Biosimilars Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Retinal Biosimilars Sales Market Share by Type (2016-2026)
Figure 49. Europe Retinal Biosimilars Sales Market Share by Application (2016-2026)
Figure 50. Europe Retinal Biosimilars Revenue Market Share by Country (2016-2026)
Figure 51. Germany Retinal Biosimilars Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Retinal Biosimilars Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Retinal Biosimilars Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Retinal Biosimilars Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Retinal Biosimilars Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Retinal Biosimilars Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Retinal Biosimilars Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Retinal Biosimilars Revenue Market Share by Region (2016-2026)
Figure 59. China Retinal Biosimilars Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Retinal Biosimilars Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Retinal Biosimilars Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Retinal Biosimilars Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Retinal Biosimilars Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Retinal Biosimilars Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Retinal Biosimilars Sales Market Share by Type (2016-2026)
Figure 66. South America Retinal Biosimilars Sales Market Share by Application (2016-2026)
Figure 67. South America Retinal Biosimilars Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Retinal Biosimilars Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Retinal Biosimilars Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Retinal Biosimilars Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Retinal Biosimilars Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Retinal Biosimilars Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Retinal Biosimilars Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Retinal Biosimilars Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Retinal Biosimilars Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の黄斑変性症（AMD）・その他網膜疾患市場規模・現状・予測（2021年-2027年） Macular degeneration (AMD) and other retinal diseases are mainly related to long-term and chronic light damage in macular area, choroidal vascular sclerosis, and aging of retinal pigment epithelial cells, often including Lucentis, Eylea, Avastin and other brands. Market Analysis and Insights: Global…- 世界のグリコシル化バイオシミラー市場規模・現状・予測（2021年-2027年） Glycosylated Biosimilars include mA, EPO etc in this report. Market Analysis and Insights: Global Glycosylated Biosimilars Market The global Glycosylated Biosimilars market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industr…
- 世界のペプチドバイオシミラー市場規模・現状・予測（2021年-2027年） Peptides are short chains of amino acid monomers linked by peptide (amide) bonds. The statistic scope in this report is peptides biosimilars. Market Analysis and Insights: Global Peptides Biosimilars Market The global Peptides Biosimilars market size is projected to reach US$ XX million by 2026, fro…
- 世界の網膜障害治療市場規模・現状・予測（2021年-2027年） Retina is a very sensitive and delicate part of human eye which is responsible for receiving and processing light to convert into neural signals and send to the brain for visual activity. The disorders related to retinal health include age-related macular degeneration, diabetic retinopathy, infectio…
- 世界の網膜症治療市場 2021：企業別、地域別、種類・用途別 The Retinal Disorders Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…